Plasma pro-surfactant protein B and lung function decline in smokers

Leung Janice M., Mayo John, Tan Wan, Tammemagi C. Martin, Liu Geoffrey, Peacock Stuart, Shepherd Frances A., Goffin John, Goss Glenwood, Nicholas Garth, Tremblay Alain, Johnston Michael, Martel Simon, Laberge Francis, Bhatia Rick, Roberts Heidi, Burrowes Paul, Manos Daria, Stewart Lori, Gingras Michel, Pasian Sergio, Tsao Ming-Sound, Lam Stephen, Sin Don D.

Source: Eur Respir J 2015; 45: 1037-1045
Journal Issue: April
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Leung Janice M., Mayo John, Tan Wan, Tammemagi C. Martin, Liu Geoffrey, Peacock Stuart, Shepherd Frances A., Goffin John, Goss Glenwood, Nicholas Garth, Tremblay Alain, Johnston Michael, Martel Simon, Laberge Francis, Bhatia Rick, Roberts Heidi, Burrowes Paul, Manos Daria, Stewart Lori, Gingras Michel, Pasian Sergio, Tsao Ming-Sound, Lam Stephen, Sin Don D.. Plasma pro-surfactant protein B and lung function decline in smokers. Eur Respir J 2015; 45: 1037-1045

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
“Plasma pro-surfactant protein B and lung function decline in smokers.”
Source: Eur Respir J 2016; 48: 962
Year: 2016


Plasma markers of oxidative protein damage do not correlate with lung function or COPD in smokers
Source: Eur Respir J 2006; 28: Suppl. 50, 144s
Year: 2006

Serum surfactant protein D (SPD) as a specific marker for COPD
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012

Serum endostatin is a novel marker for COPD associated to lung function decline and exacerbation
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019

Elevated C-reactive protein is associated with reduced lung function and exercise capacity in normal subjects. Are we born inflammed?
Source: Eur Respir J 2006; 28: Suppl. 50, 331s
Year: 2006

Elevation of plasma cystatin C levels in patients with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 583s
Year: 2002

Plasma surfactant protein D (SP-D) and nutritive status in patients with COPD
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013

Rapid decline in lung function in COPD is associated with decreased CD25brightFoxP3 regulatory T cells in BAL
Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses
Year: 2019

Lipid metabolite levels recovered from BAL fluid correlate with lung function of COPD patients and controls
Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases
Year: 2008


Serum surfactant protein D (SP-D) is a lung derived biomarker for COPD that is responsive to treatment with oral corticosteroids
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008


Plasma levels of soluble RAGE are lower in COPD
Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic
Year: 2009


Leptin levels are associated with reduced lung function in men with COPD
Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Year: 2021


The effect of MRP1 variants and the intensity of MRP1 protein expression in bronchial biopsies on lung function decline in COPD
Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD
Year: 2010

Osteopontin expression is increased in serum, BAL and bronchial tissue of asymptomatic smokers
Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic
Year: 2009


High-sensitive C-reactive protein is associated with reduced lung function in young adults
Source: Eur Respir J 2009; 33: 382-388
Year: 2009



Sputum Vitamin D binding protein (VDBP) GC1S/1S genotype predicts airway obstruction: a prospective study in smokers with COPD
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020


Relationship between plasma amino acid levels and lung function decline in patients with COPD
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013


Analysis of Immunoglobulin A and M gene expression and plasma cells in bronchial tissue from COPD patients with high blood eosinophil counts
Source: International Congress 2018 – Advanced profiling of immune cells in chronic lung diseases
Year: 2018



Interleukin-10 expressing regulatory B cells are decreased in blood of smokers and COPD patients
Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man
Year: 2021


Association between serum levels of clara cell secretory protein and lung function in adults from ECRHS
Source: Annual Congress 2012 - COPD: risk factors, biomarkers and diagnosis
Year: 2012